S. Hu

发表

N-linked glycosylation in the V3 region of HIV type 1 surface antigen modulates coreceptor usage in viral infection.

M. Rey-Cuillé, Y. Li, S. Hu, 2001, AIDS research and human retroviruses.

Characterization of a recombinant vaccinia virus expressing human melanoma-associated antigen p97

J. Brown, G. Plowman, S. Hu, 1988, Journal of virology.

Neutralizing antibodies against HIV-1 BRU and SF2 isolates generated in mice immunized with recombinant vaccinia virus expressing HIV-1 (BRU) envelope glycoproteins and boosted with homologous gp160.

S. Hu, P. Sridhar, J. Klaniecki, 1991, AIDS research and human retroviruses.

Thrombotic microangiopathy in the HIV-2-infected macaque.

C. Alpers, F. Eitner, K. Hudkins, 1999, The American journal of pathology.

Mosaics of gene variations in the Interleukin-10 gene promoter affect interleukin-10 production depending on the stimulation used

M. Roupelieva, P. Kremsner, D. Kube, 2004, Genes and Immunity.

Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen.

L. Chen, I. Hellstrom, K. Hellström, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Effects of mutations in glycosylation sites and disulphide bonds on processing, CD4-binding and fusion activity of human immunodeficiency virus envelope glycoproteins.

J. Ledbetter, H. Wigzell, P. Flodby, 1991, The Journal of general virology.

Induction of cytotoxic T lymphocytes specific for a syngeneic tumor expressing the E6 oncoprotein of human papillomavirus type 16.

D. Galloway, L. Chen, K. Hellström, 1992, Journal of immunology.

Evaluation of gp160 vaccinees in the hu-PBL-SCID mouse model.

P. Greenberg, L. Corey, D. Mosier, 1992, AIDS research and human retroviruses.

Synthesis of an active hybrid growth factor (GF) in bacteria: transforming GF-alpha/vaccinia GF fusion protein.

L. Madisen, D. Twardzik, J. Ranchalis, 1987, Gene.

Recombinant vaccinia virus vaccine against the human melanoma antigen p97 for use in immunotherapy.

J. Brown, G. Plowman, K. Hellström, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Detection of simian immunodeficiency virus (SIV)-specific CD8+ T cells in macaques protected from SIV challenge by prior SIV subunit vaccination

S. Kent, P. Greenberg, L. Corey, 1996, Journal of virology.

Functional roles of the V3 hypervariable region of HIV-1 gp160 in the processing of gp160 and in the formation of syncytia in CD4+ cells.

J. Ledbetter, J. B. Lewis, S. Hu, 1992, Virology.

Effect of MTP-PE liposomes and interleukin-7 on induction of antibody and cell-mediated immune responses to a recombinant HIV-envelope protein.

R. Ho, C. Faltynek, T. Bui, 1994, Journal of acquired immune deficiency syndromes.

Studies of complement-activating antibodies in the SIV/macaque model of acute primary infection and vaccine protection.

D. Montefiori, N. Letvin, K. Reimann, 1995, AIDS research and human retroviruses.

Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 protein.

M. McElrath, P. Greenberg, A. Collier, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160.

G. Barber, Shiu-Lok Hu, L. Kuller, 1992, Science.

Human immunodeficiency virus-like, nonreplicating, gag-env particles assemble in a recombinant vaccinia virus expression system

O. Haffar, S. Hu, J. Zarling, 1990, Journal of virology.

Development of a chronically catheterized maternal‐fetal macaque model to study in utero mother‐to‐fetus HIV transmission: A preliminary report

Shiu-Lok Hu, R. Ho, J. Unadkat, 1996, Journal of medical primatology.

Adenovirus‐mediated delivery of soluble ST2 attenuates ovalbumin‐induced allergic asthma in mice

X. Y. Li, X. Li, H. Yin, 2012, Clinical and experimental immunology.

DNA sequence required for initiation of transcription in vitro from the major late promoter of adenovirus 2.

J. Manley, S. Hu, 1981, Proceedings of the National Academy of Sciences of the United States of America.

Processing, assembly, and immunogenicity of human immunodeficiency virus core antigens expressed by recombinant vaccinia virus.

J. Eichberg, S. Hu, P. Sridhar, 1990, Virology.

Effects of anti-gp120 monoclonal antibodies on CD4 receptor binding by the env protein of human immunodeficiency virus type 1

P. Linsley, J. Ledbetter, S. Hu, 1988, Journal of virology.

Analysis of the sites of integration of viral DNA sequences in rat cells transformed by adenovirus 2 or SV40.

M. Botchan, J. Sambrook, J. Stringer, 1980, Cold Spring Harbor symposia on quantitative biology.

Analysis of cytotoxic T lymphocyte responses to SIV proteins in SIV-infected macaques using antigen-specific stimulation with recombinant vaccinia and fowl poxviruses.

S. Kent, P. Greenberg, L. Corey, 1994, AIDS research and human retroviruses.

Adenovirus‐mediated overexpression of soluble ST2 provides a protective effect on lipopolysaccharide‐induced acute lung injury in mice

Jiayong Zhu, H. Yin, Xiangyong Li, 2011, Clinical and experimental immunology.

Protection from pathogenic SIV challenge using multigenic DNA vaccines.

N. Haigwood, D. Montefiori, P. Greenberg, 1999, Immunology letters.

The genome of Shope fibroma virus, a tumorigenic poxvirus, contains a growth factor gene with sequence similarity to those encoding epidermal growth factor and transforming growth factor alpha

G. McFadden, C. Upton, A. Purchio, 1987, Molecular and cellular biology.

Proliferative and cytotoxic T cells to AIDS virus glycoproteins in chimpanzees immunized with a recombinant vaccinia virus expressing AIDS virus envelope glycoproteins.

J. Eichberg, J. Mcclure, S. Hu, 1987, Journal of immunology.

Generation of a velogenic Newcastle disease virus from cDNA and expression of the green fluorescent protein

H. Wan, J. Veits, X. Liu, 2007, Archives of Virology.

Identification of three N-linked glycans in the V4–V5 region of HIV-1 gp 120, dispensable for CD4-binding and fusion activity of gp 120

S. Olofsson, B. Jansson, S. Olofsson, 2005, Archives of Virology.

Plasma viremia in macaques infected with simian immunodeficiency virus: plasma viral load early in infection predicts survival

N. Haigwood, J. Ranchalis, P. Johnson, 1997, Journal of virology.

Restriction analysis and homology studies of the bovine adenovirus 7 genome

S. Hu, J. Battles, D. E. Potts, 1984, Journal of virology.

Early postinfection antiviral treatment reduces viral load and prevents CD4+ cell decline in HIV type 2-infected macaques.

N. Haigwood, J. Ranchalis, A. Watson, 1997, AIDS research and human retroviruses.

HIV-specific humoral and cellular immunity in rabbits vaccinated with recombinant human immunodeficiency virus-like gag-env particles.

O. Haffar, M. Smithgall, S. Hu, 1991, Virology.

An O-linked carbohydrate neutralization epitope of HIV-1 gp 120 is expressed by HIV-1env gene recombinant vaccinia virus

J. Hansen, J. Nielsen, S. Olofsson, 2005, Archives of Virology.

Sequence homology between bovine and human adenoviruses

S. Hu, W. Hays, D. E. Potts, 1984, Journal of virology.

Conservation of DNA sequence in the predicted major late promoter regions of selected mastadenoviruses.

K. Spindler, G. Darai, C. Young, 1996, Virology.

Long-term protection of macaques against high-dose type D retrovirus challenge after immunization with recombinant vaccinia virus expressing envelope glycoproteins.

R. Benveniste, W. Morton, S. Hu, 1993, Journal of medical primatology.

Integration of viral DNA sequences in cells transformed by adenovirus 2 or SV40

M. Botchan, J. Sambrook, J. Stringer, 1980, Proceedings of the Royal Society of London. Series B. Biological Sciences.

Recent advances in antitumor vaccines.

K. Hellström, I. Hellström, S. Hu, 1992, Biotechnology.

A minimally replicative HIV-2 live-virus vaccine protects M. nemestrina from disease after HIV-2(287) challenge.

S. Kent, P. Greenberg, K. Steffy, 1998, Virology.

Protection of macaques against simian AIDS by immunization with a recombinant vaccinia virus expressing the envelope glycoproteins of simian type D retrovirus.

G. Heidecker, J. Sias, R. Benveniste, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Macaques infected with cloned simian immunodeficiency virus show recurring nef gene alterations.

F. Ruscetti, G. Heidecker, R. Benveniste, 1998, Virology.

Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile.

N. Haigwood, N. Letvin, J. Ranchalis, 1996, Immunology letters.

Recombinant subunit vaccines against primate lentiviruses.

S. Hu, 1996, AIDS research and human retroviruses.

Control of rightward transcription in coliphage lambda by the regulatory functions of phage genes N and cro.

W. Szybalski, S. Hu, 1979, Virology.

Stimulation of T of function and pL-proximal transcription by the N gene product of coliphage lambda.

W. Szybalski, J. S. Salstrom, S. Hu, 1979, Virology.

Rapid shift from virally infected cells to germinal center-retained virus after HIV-2 infection of macaques.

C. Alpers, F. Eitner, E. Clark, 2000, The American journal of pathology.

Expression of the human immunodeficiency virus gag gene in insect cells.

L. Madisen, A. Purchio, S. Hu, 1987, Virology.

Tumorigenic poxviruses: characterization of the expression of an epidermal growth factor related gene in Shope fibroma virus.

G. McFadden, C. Macaulay, S. Hu, 1990, Virology.

Nucleotide and deduced amino acid sequence of the bovine adenovirus type 3 proteinase.

S. Hu, J. Weber, M. Bourbonnière, 1990, Nucleic acids research.

Recombinant subunit vaccines as an approach to study correlates of protection against primate lentivirus infection.

R. Benveniste, W. Morton, A. Langlois, 1996, Immunology letters.

Influence of N-linked glycans in V4-V5 region of human immunodeficiency virus type 1 glycoprotein gp160 on induction of a virus-neutralizing humoral response.

J. Hansen, S. Olofsson, S. Sjölander, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Inoculation of Macaca fascicularis with simian immunodeficiency virus, SIVmne immunologic, serologic, and pathologic changes.

M. Gale, E. Clark, M. Thouless, 1990, Journal of medical primatology.

Protection of vaccinia-primed macaques against SIVmne infection by combination immunization with recombinant vaccinia virus and SIVmne gp160.

G. Barber, L. Kuller, R. Benveniste, 1993, Journal of medical primatology.

Evaluation of protective efficacy of recombinant subunit vaccines against simian immunodeficiency virus infection of macaques.

R. Benveniste, W. Morton, A. Langlois, 1992, Journal of medical primatology.

Immune responses to SIVmne envelope glycoproteins protect macaques from homologous SIV infection.

W. Morton, A. Langlois, S. Hu, 1992, AIDS research and human retroviruses.

Inhibition of virus production in peripheral blood mononuclear cells from human immunodeficiency virus (HIV) type 1-seropositive donors by treatment with recombinant HIV-like particles

J. Ledbetter, O. Haffar, M. Smithgall, 1992, Journal of virology.

Carbohydrate determinant NeuAc-Gal beta (1-4) of N-linked glycans modulates the antigenic activity of human immunodeficiency virus type 1 glycoprotein gp120.

J. Hansen, S. Olofsson, E. Sjögren-Jansson, 1992, The Journal of general virology.

Effect of nonprotective vaccination on antibody response to subsequent human immunodeficiency virus infection.

S. Pincus, S. Hu, K. Messer, 1994, The Journal of clinical investigation.

Sequence diversity of SIV(Mne) Nef in vivo and in vitro.

F. Ruscetti, G. Heidecker, L. Kuller, 1998, Journal of medical primatology.